ITN TREATMENT at the Cluster Event on Persolanized Medicine in Madrid.

The Cluster Event was organised in Madrid by Research Executive Agency, at the premises of the National Institute of Health Carlos III (ISCII), on the 6th and 7th November 2019.

Personalized Medicine refers to a medical model using characterisation of individuals’ phenotypes and genotypes (e.g. molecular profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease and/or to deliver timely and targeted prevention.”

A total of 14 ITN funded projects expressed their interest to be part of the Cluster event. Members of the projects consortia and ESRs participated in the Cluster Event .

This Cluster Event on Personalised Medicine was split into three complementary phases:

(1) The researchers present their contribution to policy activities

(2) The policy makers present what they still need and how they can support policy activities icipated in the Cluster Event

(3) Both sides discuss how they can support each other

From the Research Executive Agency side, the organiser of the Event and representatives of REA participated in the Cluster Event

From the policy makers side, representatives of the Unit “Innovative and Personalised Medicine” of the Directorate General RTD of the European Commission also participated in the cluster event and facilitated the exchanges with the ICPerMed workshop. Members of the ICPerMed network also were invited to attend the Cluster Event.

During the first day of the event, some members of ITN Treatment gave information about the project and how Treatment is contributing on personalised medicine aspects.

Angela M. Valverde, Treatment coordinator,presented an overall overview of the Treatment project during the Tour de Table session together with other ITNs funded projects.

Two of our ESRs also participated with presentations. Ramazan Yildiz, ESR3, presented Treatment outputs on data and knowledge network and Diaja Grajales, ESR2, outputs about public and patient engagement.

Our supervisor, Francisco Abad-Santos, presented an extended analysis of the challenge to implement personalised medicine according to our experience working on the Treatment project.

A poster session was also planned. Our ESRs Vitor Da Silva, Diana Grajales and Ramazan Yildiz presented and shared their results with other ITN projects members.

On the second day, three parallel workshops were organised. The topics of these workshops were (1) Database, Biobanks and Diagnosis/Decision Support Tools, (2) Innovation, Regulatory Structures and (3) Health Systems and Patient/Public engagement.